BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31599492)

  • 21. Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1".
    da Fonseca Bastos ACS; da Silva Rezende AC; Ferreira LB; Blunck CB; Pombo-de-Oliveira MS; Emerenciano M; Gimba ERP
    Leuk Res; 2020 Apr; 91():106316. PubMed ID: 32114371
    [No Abstract]   [Full Text] [Related]  

  • 22. Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia.
    Ikeda J; Shiba N; Tsujimoto SI; Yoshida M; Nakabayashi K; Ogata-Kawata H; Okamura K; Takeuchi M; Osumi T; Tomizawa D; Hata K; Kiyokawa N; Ito S; Kato M
    Genes Chromosomes Cancer; 2019 Sep; 58(9):669-672. PubMed ID: 30869817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dural-based spindle cell neoplasm characterized by a novel MN1-KMT2A fusion gene.
    Chen S; Dickson BC; Mohammed S; Aldape K; Swanson D; Coulombe J; Zakhari N; Karimi S; Nassiri F; Zadeh G; Mamatjan Y; Wang T; Lo B; Woulfe J
    Neuro Oncol; 2019 Aug; 21(8):1082-1083. PubMed ID: 31095693
    [No Abstract]   [Full Text] [Related]  

  • 24. Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants.
    Fazio G; Bardini M; De Lorenzo P; Grioni A; Quadri M; Pedace L; Corral Abascal L; Palamini S; Palmi C; Buldini B; Vinti L; Parasole R; Barisone E; Zecca M; Favre C; Locatelli F; Conter V; Rizzari C; Valsecchi MG; Biondi A; Cazzaniga G
    Blood; 2021 Apr; 137(14):1980-1984. PubMed ID: 33512459
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of a novel KMT2A-SEPT14 fusion in acute myeloid leukemia.
    Nguyen D; Haley L; Pallavajjala A; Gojo I; Ning Y
    Leuk Lymphoma; 2018 Jan; 59(1):265-267. PubMed ID: 28573893
    [No Abstract]   [Full Text] [Related]  

  • 26. RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemia.
    Sanders MA; Kavelaars FG; Zeilemaker A; Al Hinai AS; Abbas S; Beverloo HB; van Lom K; Valk PJ
    Haematologica; 2015 Jan; 100(1):e1-3. PubMed ID: 25552680
    [No Abstract]   [Full Text] [Related]  

  • 27. A case of
    Forlenza CJ; Zhang Y; Yao J; Benayed R; Steinherz P; Ramaswamy K; Kessel R; Roshal M; Shukla N
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30455225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare case of pediatric T lymphoblastic leukemia with t(11;17)(q23;q21) involving mixed-lineage leukemia gene rearrangement.
    Kim H; Lee JK; Lee JA; Hong YJ; Hong SI; Jo HS; Chang YH
    Ann Lab Med; 2016 Jan; 36(1):64-6. PubMed ID: 26522762
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene.
    Szotkowski T; Jarošová M; Zimmermannová O; Meyer C; Marschalek R; Zuna J; Hubáček J; Indrák K
    Cancer Genet; 2015 Dec; 208(12):610-4. PubMed ID: 26556690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of pediatric acute myeloid leukemia with t(11;16)(q23;q24) leading to a novel KMT2A-USP10 fusion gene.
    Zerkalenkova E; Lebedeva S; Kazakova A; Baryshev P; Meyer C; Marschalek R; Novichkova G; Maschan M; Maschan A; Olshanskaya Y
    Genes Chromosomes Cancer; 2018 Oct; 57(10):522-524. PubMed ID: 30107050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MLL-TFE3: a novel and aggressive KMT2A fusion identified in infant leukemia.
    Kosasih HJ; Davidson NM; Bjelosevic S; Morrish E; Brennan MS; Oshlack A; Johnstone RW; Brumatti G; Khaw SL; Ekert PG
    Blood Adv; 2020 Oct; 4(19):4918-4923. PubMed ID: 33035331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A New Complex Karyotype Involving a KMT2A-r Variant Three-Way Translocation in a Rare Clinical Presentation of a Pediatric Patient with Acute Myeloid Leukemia.
    Capela de Matos RR; Ney Garcia DR; Othman MAK; Moura Ferreira G; Melo JB; Carreira IM; Meyer C; Marschalek R; Costa ES; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Cytogenet Genome Res; 2019; 157(4):213-219. PubMed ID: 30974445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptic t(6;11) KMT2A rearrangement in a pediatric acute myeloid leukemia patient detected by next-generation sequencing and dual-fusion FISH analysis.
    Raghunandan S; Jain J; Saxe D; Pauly M; Aljudi AA; Ketterling RP; Carter AB; Raikar SS
    Pediatr Blood Cancer; 2022 Mar; 69(3):e29428. PubMed ID: 34766724
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary Cutaneous Diffuse Large B-Cell Lymphoma With KMT2A-MLLT3: An Infantile Case Study.
    Hiroki H; Yoshimi A; Kato K; Yanai T; Koike K
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):657-658. PubMed ID: 31205223
    [No Abstract]   [Full Text] [Related]  

  • 35. KMT2A-CBL fusion in rapidly progressive myeloid disorder.
    Chaum M; Vail E; Schreck R; Lorber J; Eno CC
    Cancer Genet; 2022 Aug; 266-267():90-92. PubMed ID: 35933946
    [No Abstract]   [Full Text] [Related]  

  • 36. Subclonality and prenatal origin of RAS mutations in KMT2A (MLL)-rearranged infant acute lymphoblastic leukaemia.
    Emerenciano M; Barbosa Tda C; de Almeida Lopes B; Meyer C; Marschalek R; Pombo-de-Oliveira MS
    Br J Haematol; 2015 Jul; 170(2):268-71. PubMed ID: 25613690
    [No Abstract]   [Full Text] [Related]  

  • 37. KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia.
    Khater F; Lajoie M; Langlois S; Healy J; Cellot S; Richer C; Beaulieu P; St-Onge P; Saillour V; Minden M; Marzouki M; Krajinovic M; Bittencourt H; Sinnett D
    Blood; 2017 Mar; 129(12):1729-1732. PubMed ID: 28069604
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in
    Fournier E; Inchiappa L; Delattre C; Pignon JM; Danicourt F; Bemba M; Roche-Lestienne C; Daudignon A; Decool G; Roumier C; Dumezy F; Fournier L; Grardel N; Preudhomme C; Duployez N
    Leuk Lymphoma; 2019 Jul; 60(7):1827-1830. PubMed ID: 30616415
    [No Abstract]   [Full Text] [Related]  

  • 39. Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion.
    Wang Z; Shi Y; Liu H; Liang Z; Zhu Q; Wang L; Tang B; Miao S; Ma N; Cen X; Ren H; Dong Y
    Hematol Oncol; 2019 Dec; 37(5):617-625. PubMed ID: 31701557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mature B-cell acute lymphoblastic leukaemia associated with a rare MLL-FOXO4 fusion gene.
    Lim L; Chen KS; Krishnan S; Gole L; Ariffin H
    Br J Haematol; 2012 Jun; 157(6):651. PubMed ID: 22429121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.